Transthoracic Needle Biopsy Using 3D Printed Navigational Template: A Phase I Feasibility Trial
Transthoracic Needle Biopsy for the Diagnosis of Pulmonary Nodule Using Three-dimensional Printed Navigational Template: A Phase I Feasibility Trial
1 other identifier
interventional
20
1 country
1
Brief Summary
This study evaluates the feasibility of three-dimensional printed template in transthoracic pulmonary nodule biospy. Investigator planned to include 20 patients with lung nodule biopsy schedule to receive template-guided transthoracic needle aspiration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2017
CompletedFirst Posted
Study publicly available on registry
October 30, 2017
CompletedStudy Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 3, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 3, 2020
CompletedFebruary 25, 2021
February 1, 2021
2 months
October 26, 2017
February 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success rate of needle insertion
Clinician evaluate the relative position between biopsy needle and the target lesion on CT images after needle insertion.
15 minutes
Secondary Outcomes (2)
procedural length
1 hour
radiation dosage
1 hour
Study Arms (1)
template-guided biopsy
EXPERIMENTALParticipants receive transthoracic lung biopsy guided by navigational template.
Interventions
The navigational template was created based on computed tomography data using three-dimensional technology.
Eligibility Criteria
You may qualify if:
- CT confirmed peripheral lung nodule; Nodule size larger than or equal to 3 cm; ECOG Performance Status 0-2 ; Informed consent.
You may not qualify if:
- Nodule located in the scapula region wherein biopsy needle is impeded; Nodule within 3 cm above diaphragmatic dome.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 200000, China
Related Publications (2)
Zhang L, Li M, Li Z, Kedeer X, Wang L, Fan Z, Chen C. Three-dimensional printing of navigational template in localization of pulmonary nodule: A pilot study. J Thorac Cardiovasc Surg. 2017 Dec;154(6):2113-2119.e7. doi: 10.1016/j.jtcvs.2017.08.065. Epub 2017 Sep 1.
PMID: 29017792RESULTE H, Chen J, Sun W, Zhang Y, Ren S, Shi J, Wen Y, Su C, Ni J, Zhang L, He Y, Chen B, Casal RF, Kheir F, Ishiwata T, Zhang J, Zhao D, Chen C. Three-dimensionally printed navigational template: a promising guiding approach for lung biopsy. Transl Lung Cancer Res. 2022 Mar;11(3):393-403. doi: 10.21037/tlcr-22-172.
PMID: 35399565DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chang Chen, MD,Ph.D
Shanghai Pulmonary Hospital, Shanghai, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
October 26, 2017
First Posted
October 30, 2017
Study Start
June 1, 2020
Primary Completion
August 3, 2020
Study Completion
September 3, 2020
Last Updated
February 25, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share